Two Studies Challenge Avastin’s Effectiveness | Cancer - Advances, Knowledge, Integrative & Holistic Treatments | Scoop.it
The findings could lead the F.D.A. to revoke the drug’s approval for the treatment of glioblastoma, a rare brain cancer.